Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia.
Kato
Jun
J
Mori
Takehiko
T
Sugita
Kayoko
K
Murata
Mitsuru
M
Ono
Yukako
Y
Yamane
Akiko
A
Shimizu
Takayuki
T
Okamoto
Shinichiro
S
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols; D016470:Bacteremia / Q000209:etiology*; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage*; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D013210:Staphylococcus / Q000302:isolation & purification*
D000970:Antineoplastic Agents; D003561:Cytarabine; D015255:Idarubicin
J Clin Microbiol. 2005 Jan;43(1):363-7
15634995
Microbiology (Reading). 1999 Aug;145 ( Pt 8):2033-2042
10463169
Open Microbiol J. 2009 Apr 30;3:67-8
19543552
Eur J Clin Microbiol Infect Dis. 1998 Jan;17(1):61-2
9512188
J Clin Microbiol. 1997 Oct;35(10):2537-41
9316903
J Med Microbiol. 2008 Jul;57(Pt 7):904-906
18566153
Antimicrob Agents Chemother. 1992 Feb;36(2):429-34
1605606
Antimicrob Agents Chemother. 1991 Jan;35(1):174-6
2014973
J Infect. 1998 Jul;37(1):66-7
9733383
J Clin Microbiol. 1995 Apr;33(4):888-92
7790455